0% found this document useful (0 votes)
31 views3 pages

Lec 4 Pharma

Uploaded by

Ahmed Mohamed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
31 views3 pages

Lec 4 Pharma

Uploaded by

Ahmed Mohamed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 3

Lec 4 pharma

Rheumatoid Arthritis
⚫It is chronic autoimmune disease characterized by inflammation of joints and may affect
other organ systems.
✓ The exact cause is unknown. Genetic factors plays an important role.
✓ Activation of T cell, B cells and production
of autoantibodies leads to production of
mediators as TNF α and IL-1 which cause
joint inflammation, cartilage destruction,
bone erosion and deformity.

Pathophysiology

1|Page
Lec 4 pharma

Clinical manifestation:
A- Articular manifestation.
o Small joints of hands and feet are most commonly affected.
o In severe cases, larger joints as shoulder and knee are also affected.
o The affected joints become swollen, warm, painful and stiff.
o These manifestation increase in the morning (prominent feature).
B- Extra articular manifestation:
Other organs may be affected as lung, heart, kidney, liver.

Diagnosis:
1. Joint x-ray
2. Blood test for autoantibodies as rheumatoid factor.

❖ Management:
I-Steroidal anti-inflammatory drugs:
As corticosteroids ( prednisolone)
II-Non- steroidal anti-inflammatory drugs:
A-Rapidly acting anti – rheumatic drugs:
Large doses of NSAID are required they are used to relief pain and inflammation but
do not prevent joint destruction.
B- Slow acting anti-rheumatic drugs: Disease modifying anti-Rheumatic drugs (DMARDS):
- As it takes 6 weeks to 6 months to become evident. They are slow
acting if compared with NSAIDS.

1- Methotrexate 2-Chloroquine 3-Sulfasalazine


4-Leflunamide 5-Azathioprine 6-Cyclosporine
7-Gold salts
8-Monoclonal antibodies: a-Infliximab and Etanercept b-Rituximab
9- Anakinra
1- Methotrexate
-It is folic acid antagonist.
-It is one of 1st line drugs being used in RA cases.
-It inhibits multiple enzyme needed for activation of T-cells.
-It is given once weekly oral.
-Side effect:
hepatotoxicity- bone marrow depression- teratogenicity.

2|Page
Lec 4 pharma

2-Chloroquine
-It is antimalarial drug.
-It has role in the of RA as it decrease response of T- Cells to antigen and stabilize lysosomes.
-Side effects:
-Nausea, vomiting, Pruritis, Dermatitis.
-long term use cause retinopathy and ototoxicity.
3-Sulfasalazine:
-It is metabolized into 5-aminosalcylic acid which suppress T-cells and B-cells function.
-Side effects:
-Headache, Nausea, vomiting, Rash. – Neutropenia (rare).
4-Leflunamide :
-It suppress T-cells as it inhibit dihydroortate dehydrogenase leading to inhibition of pyrimidine
synthesis.
-Side effects:
-Diarrhea, Elevation in liver enzymes
6-Cyclosporine
-Potent inhibitor of T-cells as it inhibits phosphorylation of calcineurin which regulates nuclear
transcription factors in T-cells.
-Side effects: -Nephrotoxicity -Hepatotoxicity
7-Gold salts:
-It decrease release of inflammatory cytokines and inhibit phagocytosis
-Side effects: Dermatitis – nephrites
8-Monoclonal antibodies:
a-Infliximab and Etanercept:
-It block tumor necrosing factor α (TNFα)
-It does not cure RA, but it retard destruction of joints (it decrease signs and symptoms).
-Side effects:- Increase incidence of bacterial infection and cancers. - expensive
b-Rituximab:
-It is directed to CD20 antigen (trans membrane protein expressed on pre-B-lymphocyte).
9- Anakinra:
IL1 antagonist

3|Page

You might also like